Amphastar Pharmaceuticals (AMPH) News Today $30.62 +0.36 (+1.19%) Closing price 04:00 PM EasternExtended Trading$30.64 +0.02 (+0.08%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AMPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Epoch Investment Partners Inc. Has $36.57 Million Holdings in Amphastar Pharmaceuticals, Inc. $AMPHAugust 29 at 6:14 AM | marketbeat.comAmerican Century Companies Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. $AMPHAugust 29 at 3:46 AM | marketbeat.comCharles Schwab Investment Management Inc. Sells 21,286 Shares of Amphastar Pharmaceuticals, Inc. $AMPHAugust 28 at 3:12 AM | marketbeat.comBank of America Forecasts Strong Price Appreciation for Amphastar Pharmaceuticals (NASDAQ:AMPH) StockAugust 28 at 2:52 AM | americanbankingnews.comHotchkis & Wiley Capital Management LLC Buys 32,630 Shares of Amphastar Pharmaceuticals, Inc. $AMPHAugust 27 at 7:00 AM | marketbeat.comMartingale Asset Management L P Trims Stock Position in Amphastar Pharmaceuticals, Inc. $AMPHAugust 27 at 5:04 AM | marketbeat.comAlgert Global LLC Takes Position in Amphastar Pharmaceuticals, Inc. $AMPHAugust 27 at 4:02 AM | marketbeat.comAmphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Invesco Ltd.August 27 at 3:37 AM | marketbeat.comAnalyzing Sol-Gel Technologies (NASDAQ:SLGL) & Amphastar Pharmaceuticals (NASDAQ:AMPH)August 27 at 2:45 AM | americanbankingnews.comAmphastar Pharmaceuticals, Inc. $AMPH Shares Bought by Systematic Financial Management LPAugust 26 at 6:38 AM | marketbeat.comVanguard Group Inc. Has $70.24 Million Holdings in Amphastar Pharmaceuticals, Inc. $AMPHAugust 26 at 3:05 AM | marketbeat.comFuller & Thaler Asset Management Inc. Boosts Stake in Amphastar Pharmaceuticals, Inc. $AMPHAugust 22, 2025 | marketbeat.comPublic Sector Pension Investment Board Acquires 25,455 Shares of Amphastar Pharmaceuticals, Inc. $AMPHAugust 21, 2025 | marketbeat.comAmphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Connor Clark & Lunn Investment Management Ltd.August 19, 2025 | marketbeat.com5 Insightful Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings CallAugust 15, 2025 | msn.com05 Insightful Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings CallAugust 14, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Raised to "Buy" at Needham & Company LLCAugust 13, 2025 | marketbeat.comAmphastar Pharmaceuticals’ Mixed Earnings Call HighlightsAugust 13, 2025 | msn.comAmphastar stock gains after licensing deal for three peptide therapiesAugust 12, 2025 | investing.comAmphastar boosts pipeline with exclusive licensing deal from Nanjing AnjiAugust 12, 2025 | msn.comAmphastar raised to Buy at Needham on iron sucrose injection approvalAugust 12, 2025 | msn.comAmphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To KnowAugust 12, 2025 | msn.comAmphastar Shares Climb on Exclusive Licensing Deal for Three Peptide TherapiesAugust 12, 2025 | msn.comAmphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales MomentumAugust 12, 2025 | benzinga.comAmphastar Pharmaceuticals, Inc.: Amphastar Announces FDA Approval for Iron Sucrose Injection, USPAugust 11, 2025 | finanznachrichten.deAmphastar stock rises after FDA approves generic iron sucrose injectionAugust 11, 2025 | uk.investing.comWhy Is Amphastar Pharmaceuticals (AMPH) Stock Soaring TodayAugust 11, 2025 | uk.finance.yahoo.comAmphastar Shares Rise Following FDA Approval of Generic Iron Sucrose InjectionAugust 11, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 12.1% - Here's WhyAugust 10, 2025 | marketbeat.comAmphastar Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats ExpectationsAugust 9, 2025 | finance.yahoo.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Cut to $25.00 by Analysts at Piper SandlerAugust 9, 2025 | marketbeat.comAmphastar Pharmaceuticals Inc (AMPH) Q2 2025 Earnings Call Highlights: Strong Vaccine Sales and ...August 9, 2025 | finance.yahoo.comAmphastar advances U.S. manufacturing expansion and signals flat 2025 revenue outlook amid competitive pressuresAugust 8, 2025 | msn.comAmphastar (AMPH) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | fool.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q2 Sales Targets, But Stock Soars 6%August 8, 2025 | finance.yahoo.comAmphastar Pharmaceuticals, Inc. (AMPH) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comAmphastar Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 8, 2025 | seekingalpha.com18,358 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by XTX Topco LtdAugust 7, 2025 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Reports Q2: Everything You Need To Know Ahead Of EarningsAugust 6, 2025 | finance.yahoo.comInvestors in Amphastar Pharmaceuticals (NASDAQ:AMPH) have unfortunately lost 47% over the last yearAugust 5, 2025 | finance.yahoo.comFloyd F. Petersen Sells 500 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) StockAugust 5, 2025 | insidertrades.comDrugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goalsAugust 2, 2025 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month Low - What's Next?August 2, 2025 | marketbeat.comFederated Hermes Inc. Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)August 2, 2025 | marketbeat.comAmphastar Pharmaceuticals (AMPH) Expected to Announce Earnings on WednesdayJuly 31, 2025 | marketbeat.comGSA Capital Partners LLP Grows Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)July 31, 2025 | marketbeat.comAmphastar Pharmaceuticals: Shares Are Interesting, And Options Even MoreJuly 29, 2025 | seekingalpha.comAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025July 29, 2025 | finanznachrichten.deVictory Capital Management Inc. Increases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)July 29, 2025 | marketbeat.com Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMPH Media Mentions By Week AMPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼1.451.04▲Average Medical News Sentiment AMPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼135▲AMPH Articles Average Week Get the Latest News and Ratings for AMPH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies NUVL News Today MRUS News Today CRSP News Today TGTX News Today CYTK News Today AAPG News Today KRYS News Today ACAD News Today ADMA News Today TLX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access